(firstQuint)Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma.

 Assessment of the 30-day mortality and major complications as well as the tumor size changes of the patients undergoing ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma.

 This is a prospective non randomized trial carried out at the Ribat University Hospital between April 2017 to March 2018.

.

 Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma@highlight

Assessment of short-term outcomes of ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma: single center non-randomized trial.

